What To Expect As Arbutus Biopharma Corp (NASDAQ: ABUS) Delivers An -16.92% Loss In 6 Months
During the last session, Arbutus Biopharma Corp (NASDAQ:ABUS)’s traded shares were 1.11 million, with the beta value of the company hitting 1.29. At the end